# Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

> **NCT03027063** · NA · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 21 (actual)

## Conditions studied

- Breast Cancer Female
- Adriamycin Toxicity

## Interventions

- **BEHAVIORAL:** 10,000 steps
- **BEHAVIORAL:** Usual Care

## Key facts

- **NCT ID:** NCT03027063
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-10
- **Final completion:** 2019-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03027063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03027063, "Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03027063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*